Symptoms were present in 50% of infected patients who developed pulmonary complications compared to 8.7% of infected patients who did not develop pulmonary complications, though this difference did not reach statistical significance ( P = .06 by Fisher's exact test; Fig 3 B).
1
0.0600
0.0600